It is hard to read this greyed out version of the abstract (one needs to pay to see the real thing, I believe), but it includes some interesting things, including related to "your main vehicle" reference in your post.
Manufacturing includes novel cell processing system with following characteristics: - Use of TFF to purify monocytes from leukapheresis material; - Differentiate the monocytes to immature DC using GM-CSF as the only cytokine; - Briefly activate the immature DC with killed BCG mycobacteria and interferon gamma - Cryopreserve the final product in single doses - Test all batches for safety and activity parameters
Preclinical Summary (re mice) - Conclusions: * Activated DC are superior to immature DC in eradicating established tumors * Activation conditions, including time of activation , are critical for optimal efficacy * Both DC-injected and non-injected tumors can be eradicated, demonstrating a systemic response * Injection of tumors with aDC confers long-term protection
Intratumoral Injection: micro-air bubbles in the tumor resulting from the injection process can be made visible ... demonstrating accurate intratumoral targeting.
T Lymphocyte Activation and Proliferation with BCG Stimulation of Patients Receiving Dendritic Cell Immunotherapy: A Phase II DCVax-Direct Trial Jeffrey Lin, Joseph Antonios, Sylvia Odesa, Horacio Soto, Robert M Prins, Linda M Liau 695 Charles E. Young Drive South Gonda 1554 Los Angeles, CA 90095
DCVax-Direct is an autologous cellular immunotherapy involving intratumoral injection to solid tumors as an adjuvant traditional therapies. The injection consists of autlogous DCs activated with bacillus Calmette Guerin (BCG) and interferon (IFN)-gamma. Culture with BCG and IFN-gamma activates DCs, upregulating cell surface proteins involved in antigen presentation and T cell stimulation. Patient peripheral blood monocytes (PBMC) and serum were collected at day 0, week 8, and week 16 before each vaccination. We hypothesize that the vaccine creates an inflammatory response, and exposure of PBMCs to BCG will cause T cell activation and proliferation. Luminex technology was used to evaluate cytokine levels in patient serum. PBMCs were labeled with Cell Proliferation Dye (CPD) and cultured with inactivated BCG, and T cell proliferation was assessed using fluorescent target array technology. Levels of proinflammatory cytokines were higher and anti-inflammatory cytokines were lower in serum collected at later time points. CD4+ and CD8+ T cells exposed to BCG showed increased proliferation in patient PBMCs collected at later time points. The data suggest that treatment with DCVax Direct promotes an inflammatory response that can decrease tumor burden through upregulation of proinflammatory cytokines. Activation and proliferation of lymphocytes exposed to BCG suggest that DCs are presenting BCG and likely tumor antigens to patient T cells allowing for a targeted immune response. Submitted by jelin@mednet.ucla.edu, under the supervision of Linda, Liau M.D. Ph.D., submited on July 24, 2014
After reading through the information on this link, our problems and discussions here about the share price of NWBO just PALE in comparison.
or...
or how about...
and finally...
Most of us have endless amounts of time left. These people don't. We don't think we're going to die tomorrow, or next week, and we don't know from what we're going to die of. I'm going to remember that the next time I stress and worry about something. Because even though it might be important, what these people are going through is far worse.